España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Revolution Medicines
RVMD
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$44.06
0.77
1.78%
At close: -
$43.80
-0.26
-0.59%
After Hours: Dec 20, 6:28 PM EDT
Get Report
Comment
Revolution Medicines (RVMD) Forecast
News
Earnings
Revolution Medicines (RVMD) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Revolution Medicines (NASDAQ:RVMD) Stock
Revolution Medicines Stock (NASDAQ: RVMD)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, December 06, 2024
Wedbush Maintains Outperform on Revolution Me...
Benzinga Newsdesk
Needham Maintains Buy on Revolution Medicines...
Benzinga Newsdesk
Thursday, December 05, 2024
Revolution Medicines Closes Upsized Public Of...
Benzinga Newsdesk
Revolution Medicines Filed For Offering Of Up...
Benzinga Newsdesk
Wednesday, December 04, 2024
HC Wainwright & Co. Maintains Buy on Revoluti...
Benzinga Newsdesk
Top 3 Health Care Stocks That Could Blast Off In December
Avi Kapoor
Reported Earlier, Revolution Medicines Prices...
Benzinga Newsdesk
Tuesday, December 03, 2024
Guggenheim Maintains Buy on Revolution Medici...
Benzinga Newsdesk
Needham Reiterates Buy on Revolution Medicine...
Benzinga Newsdesk
JP Morgan Maintains Overweight on Revolution ...
Benzinga Newsdesk
Monday, December 02, 2024
Revolution Medicines Commences Public Offerin...
Benzinga Newsdesk
Dow Dips 150 Points; ISM Manufacturing PMI Tops Estimates
Avi Kapoor
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Revolution Medicines shares are trading lower...
Benzinga Newsdesk
Stellantis, PG&E And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Avi Kapoor
Revolution Medicines Announced Key Clinical U...
Benzinga Newsdesk
Thursday, November 07, 2024
Needham Maintains Buy on Revolution Medicines...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on Revoluti...
Benzinga Newsdesk
JP Morgan Maintains Overweight on Revolution ...
Benzinga Newsdesk
Piper Sandler Maintains Overweight on Revolut...
Benzinga Newsdesk
Wednesday, November 06, 2024
Revolution Medicines Is Reiterating Projected...
Benzinga Newsdesk
Revolution Medicines Q3 EPS $(0.94) Misses $0...
Benzinga Newsdesk
Monday, October 28, 2024
Guggenheim Maintains Buy on Revolution Medici...
Benzinga Newsdesk
Oppenheimer Maintains Outperform on Revolutio...
Benzinga Newsdesk
Needham Reiterates Buy on Revolution Medicine...
Benzinga Newsdesk
Friday, October 25, 2024
Needham Reiterates Buy on Revolution Medicine...
Benzinga Newsdesk
Revolution Medicines' Pancreatic Cancer Drug ...
Benzinga Newsdesk
Thursday, October 24, 2024
Needham Reiterates Buy on Revolution Medicine...
Benzinga Newsdesk
Wednesday, October 23, 2024
Revolution Medicines Announced Encouraging An...
Benzinga Newsdesk
Monday, October 21, 2024
Revolution Medicines Doses First Patient Dose...
Benzinga Newsdesk
Monday, October 07, 2024
Needham Reiterates Buy on Revolution Medicine...
Benzinga Newsdesk
Friday, September 27, 2024
Barclays Maintains Overweight on Revolution M...
Benzinga Newsdesk
Monday, August 12, 2024
HC Wainwright & Co. Reiterates Buy on Revolut...
Benzinga Newsdesk
Thursday, August 08, 2024
JP Morgan Maintains Overweight on Revolution ...
Benzinga Newsdesk
Wedbush Reiterates Outperform on Revolution M...
Benzinga Newsdesk
Needham Maintains Buy on Revolution Medicines...
Benzinga Newsdesk
Wednesday, August 07, 2024
Revolution Medicines Q2 2024 GAAP EPS $(0.81)...
Benzinga Newsdesk
Thursday, July 18, 2024
Barclays Maintains Overweight on Revolution M...
Benzinga Newsdesk
Tuesday, July 16, 2024
Oppenheimer Maintains Outperform on Revolutio...
Benzinga Newsdesk
B of A Securities Maintains Buy on Revolution...
Benzinga Newsdesk
Top 3 Health Care Stocks That Should Keep You Up At Night This Quarter
Avi Kapoor
Microsoft To Rally Around 6%? Here Are 10 Top Analyst Forecasts For Tuesday
Avi Kapoor
HC Wainwright & Co. Maintains Buy on Revoluti...
Benzinga Newsdesk
Needham Maintains Buy on Revolution Medicines...
Benzinga Newsdesk
Friday, July 12, 2024
Barclays Initiates Coverage On Revolution Med...
Benzinga Newsdesk
Thursday, July 11, 2024
Revolution Medicines Announces Publication In...
Benzinga Newsdesk
Tuesday, July 09, 2024
Why Helen of Troy Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Revolution shares are trading higher after th...
Benzinga Newsdesk
Nvidia, Micron, Arlo Technologies And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
Monday, July 08, 2024
Revolution Medicines To Provide Update On RMC...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch